BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16525186)

  • 21. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS metastasis: an old problem in a new guise.
    Aragon-Ching JB; Zujewski JA
    Clin Cancer Res; 2007 Mar; 13(6):1644-7. PubMed ID: 17363516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive outcomes of off-pump versus on-pump coronary artery bypass: a prospective randomized controlled trial.
    Hernandez F; Brown JR; Likosky DS; Clough RA; Hess AL; Roth RM; Ross CS; Whited CM; O'Connor GT; Klemperer JD
    Ann Thorac Surg; 2007 Dec; 84(6):1897-903. PubMed ID: 18036904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive impairment in children treated for cancer: how do we measure cognitive outcomes?
    Gross-King M; Booth-Jones M; Couluris M
    J Pediatr Oncol Nurs; 2008; 25(4):227-32. PubMed ID: 18559886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbon dioxide field flooding reduces neurologic impairment after open heart surgery.
    Martens S; Neumann K; Sodemann C; Deschka H; Wimmer-Greinecker G; Moritz A
    Ann Thorac Surg; 2008 Feb; 85(2):543-7. PubMed ID: 18222261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
    Brown PD; Jensen AW; Felten SJ; Ballman KV; Schaefer PL; Jaeckle KA; Cerhan JH; Buckner JC
    J Clin Oncol; 2006 Dec; 24(34):5427-33. PubMed ID: 17135644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.
    Nathan PC; Patel SK; Dilley K; Goldsby R; Harvey J; Jacobsen C; Kadan-Lottick N; McKinley K; Millham AK; Moore I; Okcu MF; Woodman CL; Brouwers P; Armstrong FD;
    Arch Pediatr Adolesc Med; 2007 Aug; 161(8):798-806. PubMed ID: 17679663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
    Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
    J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary brain tumors in adults.
    Chandana SR; Movva S; Arora M; Singh T
    Am Fam Physician; 2008 May; 77(10):1423-30. PubMed ID: 18533376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric central nervous system germ cell tumors: a review.
    Echevarría ME; Fangusaro J; Goldman S
    Oncologist; 2008 Jun; 13(6):690-9. PubMed ID: 18586924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving clinical trials of long-term outcomes.
    Rubenfeld GD
    Crit Care Med; 2009 Jan; 37(1 Suppl):S112-6. PubMed ID: 19104210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on new treatments and developments in childhood brain tumors.
    Partap S; Fisher PG
    Curr Opin Pediatr; 2007 Dec; 19(6):670-4. PubMed ID: 18025934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials referral resource. Clinical trials in the CNS Consortia.
    Kaplan RS; Phillips PH; Cheson BD
    Oncology (Williston Park); 1996 Aug; 10(8):1183-4. PubMed ID: 8869959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.